The number of Brazilians using medicinal cannabis-based medications increased by approximately 165% in one year, representing a jump from 188,000 to 430,000 … Increase in Patients Using Medicinal Cannabis and Its Consequences
The Brazilian Patent and Trademark Office (BPTO) has just announced that it will now order the distribution and technical examination of patent … Patent applications: BPTO shifts priority to examination request dates for faster decisions in Brazil
Starting February 6, 2024, generic and branded-generic (“similar”) drugs will be allowed to have different labels than their respective standard labels with … Anvisa approves skinny labeling practice in Brazil
The enactment of Law No. 14,597/2023 (known as General Sports Law – GSL) in June of this year marks a milestone for … The protection of IP rights in the new Brazilian sports law
On October 27, the Brazilian Finance Ministry (MF) issued a significant regulatory milestone for sports betting activities (Ordinance No. 1,300/2023) which establishes the … Brazilian Finance Ministry Issues New Regulation For Sports Betting Market
On October 19, 2023, the Federal Official Gazette (DOU) published Administrative Order 1,184/2023, which provides for the National Health Surveillance Agency’s (Anvisa) … ANVISA’s Personal Data Protection Policy is released
The Interministerial Group on Intellectual Property (“GIPI’, in the Portuguese acronym), has announced its 2023-2025 Action Plan for implementing the Brazilian Intellectual … 2023 – 2025 Action Plan for the Brazilian Intellectual Property National Strategy Announced by GIPI
The chapter “Designs,” authored by our partners Viviane Trojan, Tarso Mesquita Machado, Fábio Ferreira, and specialist Felipe Florentino Lisboa, has been published in Lexology’s special … Lexology GTDT – Designs 2024
Three months after imposing the first fine on a company, the Brazilian Data Protection Authority (ANPD) issued last Friday (06/10) a new sanction … Brazilian Data Protection Authority applies the second penalty for non-compliance with LGPD
The National Health Surveillance Agency (ANVISA) has approved the opening of a Public Consultation to amend the regulation of biosimilar medicines in Brazil … Green light from ANVISA regarding the registration of biosimilar medicines in Brazil
